Abstract
Within 1 procedure, tissue-engineered, living heart valves (TEHVs), fabricated from biodegradable scaffolds seeded with autologous bone marrow–derived mononuclear cells ([Fig. 1][1]A), were integrated into self-expanding nitinol stents (20 mm × 30 mm) and transapically delivered into the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
